Optimal dosing of lasmiditan in the management of acute migraine attack: A systematic review and meta-analysis
Conclusion: An oral dosing of Lasmiditan 200 mg is ideal for the treatment of acute migraine in adult patients with CV risk factors for attaining headache pain freedom at 2 h and sustained pain freedom at 24 compared to Lasmiditan 100 mg.
Source: Annals of Indian Academy of Neurology - Category: Neurology Authors: Roopa Satyanarayan Basutkar Chris Elizabeth Vinod Shruthi Jaya Saju Bhavya Chebrolu Sivasankaran Ponnusankar Source Type: research
More News: Academies | Brain | Cardiology | Cardiovascular | Databases & Libraries | Disability | Headache | Heart | India Health | Migraine | Neurology | Pain | Pain Management | Statistics | Study